Windtree Therapeutics, Inc. (WINT)
OTCMKTS · Delayed Price · Currency is USD
0.0320
+0.0006 (1.83%)
At close: Dec 31, 2025
Windtree Therapeutics Market Cap
Windtree Therapeutics has a market cap or net worth of $1.1 million as of December 31, 2025. Its market cap has decreased by -65.29% in one year.
Market Cap
1.10M
Enterprise Value
4.38M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since November 26, 1997, Windtree Therapeutics's market cap has decreased from 4.17B to 1.10M, a decrease of -99.97%. That is a compound annual growth rate of -25.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 1.10M | -71.43% |
| Dec 31, 2024 | 3.86M | 4.27% |
| Dec 29, 2023 | 3.70M | -43.61% |
| Dec 30, 2022 | 6.56M | -85.53% |
| Dec 31, 2021 | 45.36M | -47.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 773.31M |
| Glass House Brands | 723.19M |
| Elite Pharmaceuticals | 503.55M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 355.02M |
| CytoDyn | 325.20M |
| Silence Therapeutics | 290.49M |